Back to search

France· FR:63001674

ABIRATERONE TEVA 500 mg, comprimé pelliculé

A abiraterone product, registered in France by TEVA (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L02BX03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedABIRATERONE TEVA 500 mg, comprimé pel…ATCL02BX03REGISTER NO.FR:63001674PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Abiraterone is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BX03 (abiraterone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Abiraterone · ATC L02BX03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of abiraterone costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • France: $33.07 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Abiraterone · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$42.72
  • FR France$33.07
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
TEVA (PAYS-BAS)
Country
France (FR)
ATC code
L02BX03
ATC class
Abiraterone
Defined daily dose
1 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930254301
    60 plaquettes unitaires prédécoupées PVC polychlortrifluoroéthylène PVC-Aluminium de 1 comprimé(s)
    EUR 871.44

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for abiraterone.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Abiraterone · interactions on record

461 records

  • 101 severe
  • 335 moderate
  • 25 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • LoperamideA07DA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Abiraterone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abiraterone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Abiral, Abirateron +pharma
  • Belgium · Abirateron Eg, Abirateronacetaat Eg (Eurogenerics) Nv
  • Bulgaria · Абиратерон Msn, Абиратерон Деватис
  • Cyprus · Abiraterone Farmoz, Abiraterone Pharmazac
  • Czechia · Abirateron Ashcure, Abirateron Pharmagen
  • Germany · Abibam®, Abiranio
  • Denmark · Abirateron "olpha", Abirateron "sandoz"
  • Estonia · Abiraterone G.L. Pharma, Abiraterone Norameda
  • Spain · Abiraterona Ashcure, Abiraterona Cipla
  • Finland · Abirateron Avansor, Abirateron Devatis
  • United Kingdom (Northern Ireland) · Abiraterone, Abiraterone Abdi
  • Greece · Abinone, Abiprostem
  • Croatia · Abirateron Alpha-Medical, Abirateron Devatis
  • Hungary · Abaxan, Abirateron Galenika
  • Ireland · Abiraterone, Abiraterone Aristo
  • Iceland · Abirateron, Abirateron Medical Valley
  • Italy · Abiraterone Abdi, Abiraterone Abdi Farma
  • Liechtenstein · Abiraterone Accord, Abiraterone Mylan
  • Lithuania · Abiraterone G.L. Pharma, Abiraterone Norameda
  • Luxembourg · Abirateron Eg, Abiraterone Eugia
  • Latvia · Abiraterone G.L. Pharma, Abiraterone Norameda
  • Malta · Abiraterone Ashcure, Abiraterone Clonmel
  • Netherlands · Abirateron 1a Pharma, Abirateron Abdi
  • Norway · Abirateron Devatis, Abirateron Medical Valley
  • Poland · Abiral, Abirateron Sun
  • Portugal · Abiraterona Bluepharma, Abiraterona Eugia
  • Romania · Abirateron? Lannacher, Abirateronă
  • Sweden · Abirateron Devatis, Abirateron Medical Valley
  • Slovenia · Abirateron Galenika, Abirateron Teva
  • Slovakia · Abirateron Msn, Abirateron Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8c2a27c-7515-4c69-b9cf-6661acf62db8
GET /v1/drugs/f8c2a27c-7515-4c69-b9cf-6661acf62db8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63001674",
  "date_amm": "2022-05-31",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about abiraterone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.